AngioDynamics beats top-line and bottom-line estimates; updates FY25 outlook
Source: SeekingAlpha
2025-04-02 06:34:51 ET
More on AngioDynamics
- AngioDynamics: Improving Financial Performance And Good Clinical Data Reinvigorate The Shares
- AngioDynamics: A Surgical Approach To Market Growth
- AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript
- AngioDynamics Non-GAAP EPS of -$0.04 beats by $0.07, revenue of $73.02M beats by $2.09M
- Seeking Alpha’s Quant Rating on AngioDynamics
Read the full article on Seeking Alpha
For further details see:
AngioDynamics beats top-line and bottom-line estimates; updates FY25 outlook
AngioDynamics Inc.
NASDAQ: ANGO
ANGO Trading
-2.96% G/L:
$10.50 Last:
125,269 Volume:
$10.78 Open:
ANGO Latest News
February 27, 2026 03:57:23 pm
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
February 23, 2026 04:30:00 pm
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
February 19, 2026 08:30:00 am
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform
February 05, 2026 08:00:00 am
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
ANGO Stock Data
$455,039,941
38,744,343
2.99%
58
N/A
Medical Equipment & Supplies
Healthcare
US
Latham
